Adverse neurological outcomes in Nigerian children with sickle cell disease
- 367 Downloads
Sickle cell disease (SCD) is reported to be the most common genetic disorder affecting Nigerians. Children with SCD are at a high risk of neurological morbidity. The main objective of this study was to determine the pattern of adverse neurological outcomes among a cohort of Nigerian children with SCD. All children with SCD seen in the Department of Paediatrics, University College Hospital, Ibadan, Nigeria, over a period of 2 years were carefully evaluated for symptoms and signs of neurological complications, defined as clinical outcomes referable to the central nervous system. Of the 214 children evaluated, 187 were diagnosed with Hb SS disease and 27 with Hb SC disease. Neurological complications were identified in 78 (36.4 %) of the cases. The most common complications were headache (17.8 %), seizure (9.3 %) and stroke (8.4 %). Other less frequent complications included bacterial meningitis (2.8 %), spontaneous visual loss (1.4 %), paraplegia (0.9 %) and transient ischaemic attacks (0.9 %). Neurological complications occurred more frequently in children with sickle cell anaemia than in those with Hb SC disease (P = 0.002, 95 % CI 1.450–82.870). Adverse neurological events are common in Nigerian children with SCD, with a significantly higher risk in Hb SS than Hb SC disease. Stroke represents a major underlying cause of symptomatic epilepsy in SCD. Institution of primary preventive measures for stroke in SCD will significantly reduce the burden of stroke and epilepsy associated with SCD in Nigeria.
KeywordsSickle cell disease Neurological Complications Stroke
The authors acknowledge the support of the resident doctors, Department of Paediatrics, UCH, Ibadan.
Conflict of interest
The authors have nothing to disclose and there is no conflict of interest.
- 1.Ohene-Frempong K. Abnormalities of haemoglobin structure and function. Sickle Cell Disease. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ, editors. Rudolph pediatrics. New York: McGraw Hill Medical Publishing Division, 2003. p. 1534–40.Google Scholar
- 2.Saunthararajah Y, Vichinsky EP, Embury SH. Sickle cell disease. In: Hoffman R, Benz EJ, Shattil SJ, et al., editors. Haematology basic principles and practice. Philadelphia: Elsevier; 2005. p. 605–43.Google Scholar
- 3.Serjeant GR. Sickle cell disease. Oxford: Oxford University Press; 1985. p. 1–12.Google Scholar
- 5.Elion J, Laurance S, Lapoumeroulie C. Pathophysiology of sickle cell disease. Med Trop (Mars). 2010;70:454–8.Google Scholar
- 16.Lagunju IA, Brown BJ, Famosaya A. Childhood stroke in sickle cell disease. J Ped Neurol. 2011;9:49–53.Google Scholar
- 17.Lewis DW. Headaches in Infants and Children. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology principles and practice (Fourth Edition). Philadelphia:Mosby Elseiver; 2006. p. 1183–202.Google Scholar
- 18.Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia. 1993;34:592.Google Scholar
- 24.Adams RJ. Neurological complications. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, editors. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1994. p. 599–621.Google Scholar